The old one-two

The underdog pharmaceutical industry finally has a wingman in their role of David vs. the Goliath of government regulators! (What's the emoticon for dripping sarcasm?)

This CMAJ article discusses Canwest Global Communication's upcoming challenge to the government's ban on direct-to-consumer drug advertising. Dr. John Abramson, of Harvard Medical School, begs to differ.

But, according to Canwest, the ban is a breach of the Charter of Rights and Freedoms.

Pay no attention to the big bags of cash behind the curtain.